These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 170826

  • 1. Evaluation of serum progesterone during treatment of malignant trophoblastic disease.
    Dawood MY.
    Am J Obstet Gynecol; 1975 Oct 01; 123(3):291-8. PubMed ID: 170826
    [Abstract] [Full Text] [Related]

  • 2. Serum progesterone and serum human chorionic gonadotropin in gestational and nongestational choriocarcinoma.
    Dawood MY.
    Am J Obstet Gynecol; 1975 Dec 01; 123(7):762-5. PubMed ID: 1200070
    [Abstract] [Full Text] [Related]

  • 3. Differential production of human chorionic gonadotropin and free subunits in gestational trophoblastic disease.
    Ozturk M, Berkowitz R, Goldstein D, Bellet D, Wands JR.
    Am J Obstet Gynecol; 1988 Jan 01; 158(1):193-8. PubMed ID: 2447774
    [Abstract] [Full Text] [Related]

  • 4. Radioimmunoassay of the serum free beta-subunit of human chorionic gonadotropin in trophoblastic disease.
    Fan C, Goto S, Furuhashi Y, Tomoda Y.
    J Clin Endocrinol Metab; 1987 Feb 01; 64(2):313-8. PubMed ID: 2432080
    [Abstract] [Full Text] [Related]

  • 5. Serum progesterone and serum chorionic gonadotrophin in hydatidiform mole and choriocarcinoma.
    Teoh ES, Das NP, Dawood MY, Ratnam SS.
    Acta Endocrinol (Copenh); 1972 Aug 01; 70(4):791-800. PubMed ID: 5068403
    [No Abstract] [Full Text] [Related]

  • 6. Diagnostic reliability of simultaneous measurements of beta human chorionic gonadotropin and pregnancy-specific beta-1-glycoprotein in serum of patients with trophoblastic disease.
    Takayama M, Soma H, Isaka K, Okudera K, Ogawa T, Kikuchi K.
    Gynecol Obstet Invest; 1987 Aug 01; 23(3):151-6. PubMed ID: 3036671
    [Abstract] [Full Text] [Related]

  • 7. Serum granulocyte macrophage colony stimulating factor (GM-CSF) in gestational trophoblastic diseases.
    Shaarawy M, el-Shobokshy AS, el-Noury AI.
    Cytokine; 1995 Feb 01; 7(2):171-5. PubMed ID: 7540057
    [Abstract] [Full Text] [Related]

  • 8. [Fluctuations of plasma progesterone, 17alpha-OH-progesterone and estrogens in trophoblastic diseases (author's transl)].
    Miyamoto T.
    Nihon Naibunpi Gakkai Zasshi; 1977 Mar 20; 53(3):203-20. PubMed ID: 199477
    [No Abstract] [Full Text] [Related]

  • 9. Serum progesterone monitoring in post-molar surveillance.
    Vasilev SA, Schlaerth JB, Ahn C, Sauer MV.
    Gynecol Oncol; 1994 Sep 20; 54(3):288-91. PubMed ID: 7522199
    [Abstract] [Full Text] [Related]

  • 10. Serum placental lactogen activity in patients with molar pregnancy and trophoblastic tumors--a reliable index of malignancy.
    Goldstein DP.
    Am J Obstet Gynecol; 1971 Jun 15; 110(4):583-7. PubMed ID: 4325820
    [No Abstract] [Full Text] [Related]

  • 11. Serum SP1, hPL and beta-hCG levels in trophoblastic diseases.
    Zhang WY, Yen GL.
    Chin Med J (Engl); 1991 Dec 15; 104(12):995-8. PubMed ID: 1723674
    [Abstract] [Full Text] [Related]

  • 12. The significance of serum progesterone and serum unconjugated oestradiol-17beta in unaborted hydatidiform mole.
    Dawood MY.
    Acta Endocrinol (Copenh); 1975 Aug 15; 79(4):729-39. PubMed ID: 169657
    [Abstract] [Full Text] [Related]

  • 13. Trophoblastic disease monitoring: Evaluation of pregnancy-specific beta 1-glycoprotein.
    O'Brien TJ, Engvall E, Schlaerth JB, Morrow CP.
    Am J Obstet Gynecol; 1980 Oct 01; 138(3):313-20. PubMed ID: 6251725
    [Abstract] [Full Text] [Related]

  • 14. The clinical evaluation of the simultaneous measurements of human chorionic gonadotropin (hCG) and its alpha-subunit in sera of patients with trophoblastic diseases.
    Nishimura R, Ashitaka Y, Tojo S.
    Endocrinol Jpn; 1979 Oct 01; 26(5):575-83. PubMed ID: 527560
    [Abstract] [Full Text] [Related]

  • 15. Radioimmunoassay of the beta-subunit of human chorionic gonadotropin, monitor of chemotherapy in gestational trophoblastic neoplasm.
    Jones WB, Lehr M, Lewis JL.
    Surg Forum; 1973 Oct 01; 24():563-5. PubMed ID: 4377042
    [No Abstract] [Full Text] [Related]

  • 16. Pregnancy-specific beta-1-glycoprotein in trophoblastic disease.
    Rutanen EM, Seppälä M.
    J Clin Endocrinol Metab; 1980 Jan 01; 50(1):57-61. PubMed ID: 6243133
    [No Abstract] [Full Text] [Related]

  • 17. Serum levels of macrophage colony-stimulating factor in trophoblastic disease.
    Kohorn EI, Kacinski BM, Stanley ER.
    Gynecol Oncol; 2001 Mar 01; 80(3):383-6. PubMed ID: 11263936
    [Abstract] [Full Text] [Related]

  • 18. Serum relaxin in patients with invasive mole, choriocarcinoma and persistent trophoblastic disease.
    Seki K, Uesato T, Kato K.
    Endocrinol Jpn; 1986 Oct 01; 33(5):727-33. PubMed ID: 3030714
    [Abstract] [Full Text] [Related]

  • 19. The human chorionic gonadotropin molecule from patients with trophoblastic diseases has a high thyrotropic activity but is less active in the ovary.
    Kato K, Mostafa MH, Mann K, Schindler AE, Hoermann R.
    Gynecol Endocrinol; 2004 May 01; 18(5):269-77. PubMed ID: 15346663
    [Abstract] [Full Text] [Related]

  • 20. [HCG and SP1 in serum of patients with hydatidiform mole and chorionepithelioma--relative serum levels of both proteins in correlation to malignancy of the trophoblastic disease].
    Braun P, Leyendecker G.
    Arch Gynecol; 1979 Jul 20; 228(1-4):663-4. PubMed ID: 485549
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.